Traditional Clinical and Pathologic Factors Cannot Predict the Breast Recurrence Score™ Result

The Oncotype DX® Breast Recurrence Score result reflects the individual biology of estrogen receptor (ER)–positive patients; traditional, population-based factors such as tumor size, tumor grade, and patient age do not. This insight enables physicians to assess risk based on a patient’s specific underlying disease.1

Tumor size does not reveal the whole picture of the tumor biology1

Tumor Size

 

Patient age does not reveal the whole picture of the tumor biology1

Patient Age

 

Tumor grade does not reveal the whole picture of the tumor biology1

Grading by Pathology

 

The Breast Recurrence Score result provides significant and consistent information
beyond traditional clinical and pathological features analyzed.1-2

 

REFERENCES
1. Paik et al. J Clin Oncol. 2006.
2. Paik et al. New Engl J Med. 2004.

 

Next: Comparing Assays